Eurofins a global major in bio-analytical testing, is all set to expand its operations in India with opening of a new facility in Bengaluru. It sees ample prospects in India to help garner growth at the global level from current Euro 1.3 billion to Euro 2 billion by 2017.

By September, 2014, Eurofins will have staff strength of around 300 in India. Over the next 2-3 years, Eurofins plans to significantly ramp up its headcount.

Since 2009, the company has been present in India and has expanded from a single business to multiple businesses over the last few years. Currently it operates overall five businesses in India. Of these four are genomics; food & feed testing; pharma services and IT solutions. The new facility includes a mix of labs and offices built over 48,357 sq ft. and is located at Hoodi, Whitefield, Bengaluru while AgroScience Services, operates from Coimbatore, Tamil Nadu.

The global bio-analytical testing company is looking to consolidate its operations and tap the growth opportunities in the market.

“This new facility demonstrates our commitment to the Indian market, which is strategically important for our growth in the long term. Eurofins is one of the few international players in the testing business to invest in a wholly owned facility in India. We will expand our offering to bring more and more of the Eurofins portfolio of services to customers here,” said Dr Matthias-Wilbur Weber, group executive vice president, Eurofins Scientific.

“India is a critical market, which is strategically important for our future growth. We would pursue dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods,” he added.

“The pace of growth and diversity of activities meant that all entities could not be accommodated in single rented premises. With most of our businesses are able to achieve profitability within a short time, it is possible that India will continue to be an attractive market for Eurofins and we shall continue to grow our presence here,” said Sanjeev Khatri, managing director, Eurofins India.

With over 15,000 staff in more than 190 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products.

The company stated that its customers include many of the largest global pharma companies. Most of these companies are present locally and use Eurofins’ services. Further, leading private and public research institutions are part its client list.